New Jersey Medical Marijuana Panel Approves 5 New Qualifying Conditions – News

New Jersey’s notoriously strict medical marijuana program may be on the road to expansion, thanks to the approval of five new ailments as qualifying conditions for medical cannabis by state regulators. Patch reports that the state’s Medicinal Marijuana Review Panel has approved anxiety, migraines, Tourette’s Syndrome, “chronic pain related to musculoskeletal disorders,” and “chronic pain of visceral origin (related to internal organs)” as conditions for which a doctor can recommend a cannabis-based treatment.

The panel gave a tentative approval to these five conditions back in May, followed by a 60-day waiting period to solicit public comments. This week, the panel reconvened to make their final decision on the new conditions, approving them with a 5-to-1 vote. Asthma and chronic fatigue syndrome were also proposed as qualifying conditions, but the panel voted unanimously against allowing either.

In order to become fully legal, these conditions must be approved by Health Commissioner Cathleen Bennett, who has opposed legal cannabis in the past. A New Jersey Department of Health spokesperson told Patch that Bennett has 180 days to deliver a final decision on allowing these…

Continue reading at MerryJane.com

About Merry Jane

is the definitive cannabis resource on culture, news, video, food and style dedicated to expressing a new cannabis mentality. Through exclusive content and relatable perspectives, MERRY JANE highlights the best of cannabis lifestyle while also offering vital, interactive tools to explore the new frontier of products, dispensaries and community.

Leave a Reply

Your email address will not be published. Required fields are marked *